Usana Health Sciences Inc

NYSE:USNA   3:59:59 PM EDT
-0.44 (-0.44%)
Share Repurchases, Positive Earnings Pre-Announcement

Usana Health Sciences Sees Q3 Sales $265 Mln TO $270 Mln

Published: 09/16/2021 20:26 GMT
Usana Health Sciences Inc (USNA) - USAna Health Sciences Provides Preliminary Third Quarter Results and Updates Fiscal Year 2021 Outlook; Increases Share Repurchase Authorization.
Sees Q3 Earnings per Share $1.28 to $1.33.
Sees Q3 Sales $265 Million to $270 Million.
Sees Full-year 2021 Net Sales $1.18 Billion to $1.20 Billion.
Q3 Sales Have Been Softer Than Anticipated, Largely Because of Increased Disruptions and Lockdowns Due to Pandemic.
Sees Full-year 2021 Diluted EPS to Be $5.80 to $6.00.
Less Favorable Currency Exchange Rates Also Impacted Q3, Contributed to FY Adjusted Sales Outlook.
Board Increased Share Repurchase Authorization to $150 Million.
USAna Health Sciences - in Some Markets, We Have Delayed Introduction of New Product Offerings Until 2022.
Revenue is expected to be $268.07 Million
Adjusted EPS is expected to be $1.30

Next Quarter Revenue Guidance is expected to be $278.55 Million
Next Quarter EPS Guidance is expected to be $1.31

More details on our Analysts Page.